The potential of liposomes as carriers for drug delivery and drug targeting has frequently been reported, but the production of liposomal formulations on an industrial scale remains a challenge. Consequently, a novel nano-milling unit has been developed and investigated. The new nanomill fulfils the GMP standards of the pharmaceutical industry and remains entirely closed also when cleaned, sterilised and prepared for another batch.